-
1.发明申请Universally applicable virus inactivated blood plasma produced from portions of non-caucasian plasma 审中-公开普遍适用的病毒灭活血浆是由非白血病部分血浆产生的公开(公告)号：US20070071829A1
公开(公告)日：2007-03-29
申请号：US10580548
申请日：2004-12-20
CPC分类号： A61K35/16
摘要： A blood plasma for human use pooled from donors which belong to 10% or more to a non-Caucasian population, the plasma obtainable by mixing blood or blood plasma of blood groups A and B, optionally AB without admixing substantial amounts of blood or blood plasma of blood group 0 characterized in that four to eight parts of blood or blood plasma from donors having the blood group A, more than three parts to seven parts of blood or blood plasma from donors having the blood group B, zero to two parts of blood or blood plasma from donors having the blood group AB.
摘要翻译： 属于非高加索人口10％以上的供体的人血浆是通过混合血型A和B的血液或血浆而得到的血浆，任选地AB，而不混合大量的血液或血浆 的血型0，其特征在于，具有血型A，来自具有血型B的供体的血液或血浆中的血液或血浆的血液或血浆的血液或血浆中的血液或血浆的血液或血浆为4至8份，血液为零至2份 或具有血型AB的供体的血浆。
-
2.发明申请Universally applicable virus inactivated blood plasma produced from portions of non-Caucasians plasma 审中-公开普遍适用的病毒灭活血浆由部分非高加索血浆产生公开(公告)号：US20110104298A1
公开(公告)日：2011-05-05
申请号：US12805920
申请日：2010-08-24
IPC分类号： A61K35/16
CPC分类号： A61K35/16
摘要： A blood plasma for human use pooled from donors which belong to 10% or more to a non-Caucasian population, the plasma obtainable by mixing blood or blood plasma of blood groups A and B, optionally AB without admixing substantial amounts of blood or blood plasma of blood group 0 characterized in thatfour to eight parts of blood or blood plasma from donors having the blood group A,more than three parts to seven parts of blood or blood plasma from donors having the blood group B,zero to two parts of blood or blood plasma from donors having the blood group AB.
摘要翻译： 属于非高加索人口10％以上的供体的人血浆是通过混合血型A和B的血液或血浆，任选地AB而不混合大量血液或血浆而获得的血浆 的血型0，其特征在于，具有血型A，来自具有血型B的供体的血液或血浆中的血液或血浆的血液或血浆的血液或血浆中的血液或血浆的血液或血浆为4至8份，血液为零至2份 或具有血型AB的供体的血浆。
-
公开(公告)号：US20070014806A1
公开(公告)日：2007-01-18
申请号：US11524290
申请日：2006-09-21
申请人： Wolfgang Marguerre , Tor-Einar Svae
发明人： Wolfgang Marguerre , Tor-Einar Svae
CPC分类号： A61K38/16
摘要： A universally applicable blood plasma obtainable by a process comprising the steps of mixing blood or blood plasma of blood groups A and B optionally blood or blood plasma of blood group AB without admixing substantial amounts of blood or blood plasma derived from blood group 0.
摘要翻译： 一种普遍适用的血浆，其可通过包括以下步骤的方法获得：血液或血型A和B任选血液或血浆AB血液或血浆，而不混合大量来自血型0的血液或血浆。
-
公开(公告)号：US20110008459A1
公开(公告)日：2011-01-13
申请号：US12923380
申请日：2010-09-17
申请人： Wolfgang Marguerre , Tor-Einar Svae
发明人： Wolfgang Marguerre , Tor-Einar Svae
CPC分类号： A61K35/16
摘要： A universally applicable blood plasma obtainable by a process comprising the steps of mixing blood or blood plasma of blood groups A and B optionally blood or blood plasma of blood group AB without admixing substantial amounts of blood or blood plasma derived from blood group 0.
摘要翻译： 一种普遍适用的血浆，其可通过包括以下步骤的方法获得：血液或血型A和B任选血液或血浆AB血液或血浆，而不混合大量来自血型0的血液或血浆。
-
公开(公告)号：US20090092678A1
公开(公告)日：2009-04-09
申请号：US12222457
申请日：2008-08-08
申请人： Wolfgang Marguerre , Tor-Einar Svae
发明人： Wolfgang Marguerre , Tor-Einar Svae
IPC分类号： A61K35/16
CPC分类号： A61K38/16
摘要： A universally applicable blood plasma obtainable by a process comprising the steps of mixing blood or blood plasma of blood groups A and B optionally blood or blood plasma of blood group AB without admixing substantial amounts of blood or blood plasma derived from blood group 0.
-
6.发明授权
公开(公告)号：US6136865A
公开(公告)日：2000-10-24
申请号：US472776
申请日：1995-06-07
CPC分类号： A61L2/0088
摘要： A method for reduction of the viral infectiousness of potentially infectious material, such as human or animal body fluids or fractions derived therefrom from which biologically active substances can be isolated, wherein the infectiousness is due to non-lipid-coated viruses characterized in thatsaid potentially infectious material for the isolation of said biologically active substances is treated witha hydrophobic phase which is essentially insoluble in water and is capable of forming a two-phase system with said potentially infectious material, andsaid hydrophobic phase is separated from the potentially infectious material thus treated.
摘要翻译： 一种降低潜在感染性物质（例如人体或动物体液或其衍生的部分）的病毒感染性的方法，由此可以分离生物活性物质，其中感染性是由于非脂质包被的病毒，其特征在于所述潜在的 用于分离所述生物活性物质的感染性物质用基本上不溶于水的疏水相处理，并且能够形成具有所述潜在传染性物质的两相体系，并且所述疏水相与潜在感染性物质分离，因此 治疗。
-
公开(公告)号：US20100145021A1
公开(公告)日：2010-06-10
申请号：US12448844
申请日：2008-01-25
申请人： Wolfgang Marguerre
发明人： Wolfgang Marguerre
IPC分类号： C07K14/75 , C07K14/745 , C07K14/755 , C07K16/00 , C07K14/79 , C07K14/47 , C07K14/475 , C07K1/30 , C07K1/00
CPC分类号： C07K16/065
摘要： A process for enhancing the recovery yield of proteins, especially plasma proteins, from sources containing the proteins, wherein the sources containing the proteins are frozen at temperatures of ≦−70° C., and the proteins from a frozen source after thawing are further processed in a per se known manner.
摘要翻译： 一种用于从含有蛋白质的来源提高蛋白质，特别是血浆蛋白质的回收率的方法，其中含有蛋白质的来源在-70℃的温度下冷冻，并且解冻后来自冷冻来源的蛋白质进一步 以本身已知的方式进行处理。
-
8.发明授权
公开(公告)号：US6007979A
公开(公告)日：1999-12-28
申请号：US952442
申请日：1998-02-19
CPC分类号： A61L2/0088
摘要： A method for reduction of the viral infectiousness of potentially infectious material, such as human or animal body fluids or fractions derived therefrom from which biologically active substances can be isolated, wherein the infectiousness is due to non-lipid-coated viruses characterized in thatsaid potentially infectious material for the isolation of said biologically active substances is treated witha hydrophobic phase which is essentially insoluble in water and is capable of forming a two-phase system with said potentially infectious material, andsaid hydrophobic phase is separated from the potentially infectious material thus treated.
摘要翻译： PCT No.PCT / EP96 / 01488 371日期1998年2月19日 102（e）1998年2月19日PCT PCT 1996年4月4日PCT公布。 WO96 / 36369 PCT公开号 日期1996年11月21日一种降低潜在感染性物质（例如人或动物体液或其衍生的级分）的病毒感染性的方法，其中可分离出生物活性物质，其中感染性是由于非脂质包被的病毒 其特征在于用于分离所述生物活性物质的所述潜在感染性材料用基本上不溶于水的疏水相处理，并且能够形成具有所述潜在传染性物质的两相体系，并且所述疏水相与 这样治疗的潜在传染性物质。
-
-
-
-
-
-
-
搜索结果
8 条记录 (耗时 0.023 秒)
